Delayed winter impacting healthcare portfolio
Muted and delayed winters led to flat growth in Chyawanprash, though inventory is expected to clear in Q4.
Dabur · Material risks, their source context, and severity in the latest available quarter.
ConCallIQ research layer
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Muted and delayed winters led to flat growth in Chyawanprash, though inventory is expected to clear in Q4.
Food inflation in fruits, vegetables, spices, and cereals remains high, potentially delaying rural recovery despite Dabur's outperformance.
The U.S. patent litigation continues to incur legal costs (~INR 20 crore per quarter), though scope has been narrowed and insurance may cover final damages.
Historical Q4 margins are lower due to product mix; management expects expansion but sequential decline is possible.